InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-33.4%
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Rapp Edward J, 董事. Director active across 2 companies, notably AbbVie Inc.. Cumulatively, 32 disclosures have been logged. Split: 3 buys · 0 sell. Total volume traded: €606k. Activity tracked since 7 May 2021. The latest transaction was disclosed on 10 July 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Rapp Edward J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报32 总计
2,670 股0Common StockSEC:0001193125-26-303481:0
60,584 股0Common StockSEC:0001193125-26-303481:1
1,118 股0Common Stock, $0.01 par valueSEC:0001171780-26-000010:0
5,182 股0Common StockSEC:0001171780-26-000008:0
2,401 股0Common StockSEC:0001171780-26-000004:0
1,883 股0Common StockSEC:0001171780-25-000006:0
62,377 股0Common StockSEC:0001819493-25-000101:0
1,203 股0Common Stock, $0.01 par valueSEC:0001415889-25-012792:0
1,407 股0Common StockSEC:0001819493-25-000056:0
1,475 股0Common StockSEC:0001819493-25-000029:0
1,065 股0Common StockSEC:0001819493-25-000010:0
1,065 股0Common StockSEC:0001819493-24-000206:0
28,694 股0Common StockSEC:0001819493-24-000115:0
1,322 股0Common Stock, $0.01 par valueSEC:0001415889-24-012528:0
445 股0Common StockSEC:0001819493-24-000052:0
650 股0Common StockSEC:0001819493-24-000012:0
15,151 股0Common StockSEC:0001819493-23-000239:0
15,151 股0Common StockSEC:0001819493-23-000190:0
444,444 股0Common StockSEC:0001819493-23-000142:0
1,450 股0Common Stock, $0.01 par valueSEC:0001415889-23-007674:0
7,936 股0Common StockSEC:0001819493-23-000068:0
7,936 股0Common StockSEC:0001819493-23-000015:0
300,000 股@ US$0.6919.8% 占其流量Common StockSEC:0001819493-22-000174:0
标准退出：2023年2月28日 (T+90)
3,378 股0Common StockSEC:0001819493-22-000129:0
115,606 股0Common StockSEC:0001819493-22-000101:0
32 条申报中的 25 条
About Rapp Edward J
RAPP EDWARD J is Administrateur at Xos, Inc. and AbbVie Inc. The record shows 32 filings in total, and among the recent sampled filings, purchases amount to EUR 605585 and sales to EUR 0, over the period from 2021-05-11 to 2026-07-14, with the modal transaction nature listed as Attribution.
